道瓊斯指數
49,097.06
漲跌
-1,101.11-2.19%
在 MEXC 探索美國生物科技板塊股票,涵蓋專注於藥物研發、基因治療及生物學研究的公司。比較股價、當日漲跌、市值和成交量,全面瞭解生物科技行業動態。

今日美股市場整體下跌,道瓊斯指數下跌 2.19%,標普 500 指數下跌 2.02%,納斯達克綜合指數下跌 2.25%。市場廣度偏弱,4,399 隻股票下跌、717 隻上漲,整體呈現偏空格局。
| # | 股票 | 52 週價格區間 | |||||
|---|---|---|---|---|---|---|---|
| 1 | 安進AMGN | $440.64 | -0.64% | 1.42M | $238.35B | $312.38 - $483.99 | 0.02% |
| 2 | 吉利德科學GILD | $166.94 | -1.04% | 2.22M | $207.06B | $116.88 - $176.58 | 0.02% |
| 3 | ModernaMRNA | $200.71 | +2.05% | 6.17M | $81.21B | $22.28 - $280.80 | 0.00% |
| 4 | IQVIA HoldingsIQV | $251.53 | -2.27% | 668.91K | $41.45B | $154.50 - $284.50 | 0.00% |
| 5 | BiogenBIIB | $247.78 | -1.28% | 628.14K | $36.63B | $160.36 - $261.00 | 0.00% |
| 6 | Revolution MedRVMD | $159.35 | +0.05% | 1.23M | $34.47B | $69.50 - $224.31 | 0.00% |
| 7 | 英賽德INCY | $116.08 | -1.24% | 474.62K | $23.66B | $89.25 - $132.60 | 0.00% |
| 8 | Medpace HoldingsMEDP | $636.64 | -1.56% | 74.89K | $17.81B | $373.00 - $693.97 | 0.00% |
| 9 | ExelixisEXEL | $66.02 | -3.33% | 1.67M | $16.11B | $39.71 - $73.69 | 0.00% |
| 10 | NeurocrineNBIX | $157.85 | -3.19% | 663.23K | $15.98B | $122.14 - $186.12 | 0.00% |
| 11 | Charles River Laboratories IntlCRL | $329.01 | -1.04% | 282.03K | $15.77B | $146.19 - $379.63 | 0.00% |
| 12 | Bio-TechneTECH | $72.70 | -0.05% | 2.44M | $11.42B | $43.20 - $72.88 | 0.00% |
| 13 | Repligen CorpRGEN | $170.18 | -1.06% | 440.78K | $10.88B | $100.99 - $198.87 | 0.00% |
| 14 | Halozyme TherapHALO | $92.36 | -3.81% | 1.62M | $10.53B | $61.23 - $134.00 | 0.00% |
| 15 | KymeraKYMR | $120.17 | -0.13% | 428.29K | $10.26B | $63.69 - $142.92 | 0.00% |
| 16 | Krystal BiotechKRYS | $314.37 | +0.08% | 157.21K | $9.32B | $203.17 - $382.54 | 0.00% |
| 17 | VaxcytePCVX | $58.68 | +0.84% | 497.34K | $9.29B | $42.40 - $90.75 | 0.00% |
| 18 | CG OncologyCGON | $81.66 | +1.59% | 1.66M | $7.29B | $37.01 - $93.95 | 0.00% |
| 19 | Twist BioscienceTWST | $112.46 | -2.54% | 1.59M | $7.05B | $25.23 - $219.71 | 0.00% |
| 20 | ImmunitybioIBRX | $6.51 | -2.46% | 7.95M | $6.93B | $1.95 - $12.43 | 0.00% |
| 21 | ImmunovantIMVT | $32.57 | -1.31% | 372.03K | $6.74B | $21.86 - $45.42 | 0.00% |
| 22 | Kodiak SciencesKOD | $97.75 | -0.05% | 276.66K | $6.14B | $19.04 - $112.79 | 0.00% |
| 23 | Scholar RockSRRK | $50.29 | +4.65% | 1.11M | $6.14B | $37.54 - $61.76 | 0.00% |
| 24 | Adaptive BiotechnologiesADPT | $28.53 | +0.76% | 817.79K | $4.62B | $12.00 - $32.21 | 0.00% |
| 25 | TarsusTARS | $76.97 | +1.55% | 329.14K | $3.80B | $53.89 - $91.53 | 0.00% |
| 26 | Crispr TherapeuticsCRSP | $38.79 | -2.89% | 2.18M | $3.76B | $38.77 - $63.45 | 0.00% |
| 27 | 雷利療法RLAY | $15.95 | -3.06% | 1.15M | $3.52B | $6.28 - $21.27 | 0.00% |
| 28 | Iovance BiotherapeuticsIOVA | $7.36 | -1.27% | 4.84M | $3.40B | $2.08 - $15.37 | 0.00% |
| 29 | Vericel Corp OrdVCEL | $58.09 | -0.87% | 323.51K | $2.96B | $28.95 - $59.75 | 0.00% |
| 30 | ADMA Biologics IncADMA | $13.29 | -1.73% | 1.93M | $2.95B | $7.21 - $20.46 | 0.00% |
| 31 | Denali TherapeuticsDNLI | $18.31 | +0.27% | 690.54K | $2.93B | $15.34 - $27.30 | 0.00% |
| 32 | BeamBEAM | $20.79 | +0.50% | 1.86M | $2.15B | $20.23 - $38.26 | 0.00% |
| 33 | BioCryst PharmaBCRX | $7.29 | +0.07% | 2.01M | $1.88B | $6.23 - $11.22 | 0.00% |
| 34 | Maze TherapeuticsMAZE | $32.09 | +2.98% | 652.71K | $1.85B | $21.95 - $53.65 | 0.00% |
| 35 | ReplimuneREPL | $19.37 | -1.36% | 939.46K | $1.84B | $1.50 - $23.54 | 0.00% |
| 36 | Hemab TherapeuticsCOAG | $39.13 | -0.08% | 118.35K | $1.83B | $23.00 - $55.42 | 0.00% |
| 37 | Recursion PharmaceuticalsRXRX | $2.67 | -5.49% | 32.05M | $1.67B | $2.50 - $5.24 | 0.00% |
| 38 | Vir BiotechVIR | $8.96 | -1.58% | 1.02M | $1.53B | $5.32 - $14.38 | 0.00% |
| 39 | AbsciABSI | $7.96 | -2.14% | 3.23M | $1.37B | $2.24 - $12.54 | 0.00% |
| 40 | NovavaxNVAX | $7.72 | -2.64% | 2.52M | $1.27B | $6.20 - $13.38 | 0.00% |
| 41 | Taysha GeneTSHA | $3.81 | -4.39% | 1.29M | $1.24B | $3.46 - $7.30 | 0.00% |
| 42 | Vor BiopharmaVOR | $18.26 | +2.80% | 557.58K | $1.12B | $6.50 - $26.00 | 0.00% |
| 43 | Inhibrx BiosciencesINBX | $75.62 | +13.05% | 275.46K | $1.11B | $57.30 - $155.29 | 0.00% |
| 44 | Odyssey TherapeuticsODTX | $18.34 | -2.34% | 269.74K | $930.59M | $15.10 - $29.05 | 0.00% |
| 45 | MeiraGTxMGTX | $8.15 | -1.26% | 321.82K | $796.50M | $6.62 - $15.35 | 0.00% |
| 46 | Monte Rosa TherapeuticsGLUE | $8.88 | -2.09% | 644.75K | $759.22M | $8.75 - $25.77 | 0.00% |
| 47 | OmniAbOABI | $5.04 | +0.39% | 1.13M | $734.99M | $1.35 - $5.45 | 0.00% |
| 48 | Aura BiosciencesAURA | $6.96 | -2.31% | 220.88K | $724.36M | $4.73 - $9.54 | 0.00% |
| 49 | Solid BiosciencesSLDB | $6.37 | +1.10% | 873.12K | $710.40M | $4.40 - $11.45 | 0.00% |
| 50 | Prime MedicinePRME | $3.77 | -0.52% | 2.46M | $684.70M | $2.67 - $5.91 | 0.00% |
| 現貨美股(RealStocks) | 代幣化美股(Tokenized Stocks) | 股票合約(Stock Futures) | |
|---|---|---|---|
| 是什麼 | 美股上市公司的真實股份(現貨美股) | 與美股/ETF 掛鉤的區塊鏈代幣 | 以 USDT 保證金進行的股價合約交易 |
| 所有權 | 是 —— 真實持股 | 否 —— 僅為合成敞口 | 否 —— 僅為衍生品敞口 |
| 股東權益 | 有(如分紅) | 無 | 無 |
| 交易時間 | 美股交易時段(盤前、正常、盤後、隔夜) | 24/7 全天候 | 支援交易對最高可達 24/7 全天候 |
| 持倉方式 | 買入並持有 | 買入並持有 | 支援多空雙向、槓桿交易 |
| 適合人群 | 追求長期持有和分紅收益的投資者 | 希望全天候獲得股票敞口、無需持有股票的交易者 | 希望通過槓桿進行投機或對沖的短線/活躍交易者 |
通過 MEXC 合作的持牌券商購買真實美股,並可按適用條件享有股息等股東權益。
覆蓋 7,000+ 隻美國上市股票及 ETF,涵蓋科技、金融、醫療、消費等多個行業。
支持 USDT 轉入及 USDT/USD 轉換,更便捷地為 RealStocks 帳戶提供資金。
以具有競爭力的交易成本參與真實美股交易,讓更多資金用於投資策略。
本頁面展示的美股價格、指數、排行榜、圖表及其他市場數據可能來自第三方數據提供商,並可能存在延遲或誤差。MEXC 提供的相關信息僅供參考和教育用途,不對其準確性或完整性作出保證。頁面內容不構成任何金融或投資建議,也不構成買賣任何證券的推薦。美股交易存在風險,歷史表現不代表未來結果,用戶應在作出投資決定前進行獨立研究。